Molecular Profiling in the Treatment of CRC

Molecular Profiling in the Treatment of CRC

obr

3 months
162 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Leonard Saltz, MD, Executive Director for Clinical Value and Sustainability, Colorectal Oncology Section, Memorial Sloan Kettering Cancer Center addresses molecular profiling in the treatment of colorectal cancer (CRC).
Up Next Autoplay
BEACON Trial: What's Next?
BEACON Trial: What's Next?
Category: Colorectal Cancer
3 Views
Cancer-News 4 days
Phase 3 BEACON CRC Trial
Phase 3 BEACON CRC Trial
Category: Colorectal Cancer
60 Views
Cancer-News 4 days
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Category: Colorectal Cancer
26 Views
Cancer-News 2 weeks
How does this affect treatment?
How does this affect treatment?
Category: Colorectal Cancer
8 Views
Cleveland Clinic 1 month
Is this truly safe?
Is this truly safe?
Category: Colorectal Cancer
1 Views
Cleveland Clinic 1 month
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Category: Colorectal Cancer
10 Views
Cleveland Clinic 1 month
IDEA: Factors to consider
IDEA: Factors to consider
Category: Colorectal Cancer
2 Views
moasc 1 month
The impact the IDEA data will have on clinicians
The impact the IDEA data will have on clinicians
Category: Colorectal Cancer
1 Views
moasc 1 month
IDEA: 3 vs. 6 months
IDEA: 3 vs. 6 months
Category: Colorectal Cancer
1 Views
moasc 1 month
The IDEA Collaboration
The IDEA Collaboration
Category: Colorectal Cancer
4 Views
moasc 1 month